Summary
Updated Aug 30, 2026
Lawrence Blatt is President and CEO of Aligos Therapeutics, Inc. (ALGS). 2 SEC Form 4 filings on record going back to 2025, most recently on 11 March 2026.
Trading Pattern
InsiderAlpha's records for Lawrence Blatt go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Lawrence Blatt's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Reuven Yeganeh - $33.32M of PHGE open-market activity in the last 12 months
- Adage Capital Management, L.P. - $33.20M of PRAX open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $33.00M of REPL open-market activity in the last 12 months
- Casdin Capital, LLC - $32.57M of WGS open-market activity in the last 12 months
- Paul B. Manning - $31.74M of LQDA open-market activity in the last 12 months
- LILLY ENDOWMENT INC - $3.10B of LLY open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Lawrence Blatt?
Lawrence Blatt is a corporate insider, tracked as President and CEO of Aligos Therapeutics, Inc. (ALGS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Lawrence Blatt last file a Form 4?
The most recent primary Form 4 on record is dated 11 March 2026, one of 2 filings going back to 2025.
Where can I see all of Lawrence Blatt's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Lawrence Blatt and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial